SMITH ASSET MANAGEMENT GROUP LP - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 81 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q1 2020$260,000
-0.8%
4,6010.0%0.01%
+27.3%
Q4 2019$262,000
+6.5%
4,6010.0%0.01%
+22.2%
Q3 2019$246,000
-10.5%
4,6010.0%0.01%0.0%
Q2 2019$275,000
-12.1%
4,601
-8.3%
0.01%
-10.0%
Q1 2019$313,000
-6.3%
5,016
-9.0%
0.01%
-16.7%
Q4 2018$334,000
-7.0%
5,511
-10.3%
0.01%
+20.0%
Q3 2018$359,000
+30.1%
6,1440.0%0.01%
+25.0%
Q2 2018$276,000
+1.8%
6,144
+0.4%
0.01%
-11.1%
Q1 2018$271,000
-1.1%
6,117
-3.2%
0.01%0.0%
Q4 2017$274,000
-6.8%
6,3160.0%0.01%
-10.0%
Q3 2017$294,000
-12.8%
6,316
-7.3%
0.01%0.0%
Q2 2017$337,000
-37.1%
6,816
-30.4%
0.01%
-33.3%
Q1 2017$536,000
-1.7%
9,7880.0%0.02%
-6.2%
Q4 2016$545,000
+18.2%
9,788
-3.0%
0.02%
+14.3%
Q3 2016$461,000
+17.3%
10,088
+2.4%
0.01%
+16.7%
Q2 2016$393,000
+2707.1%
9,848
+2374.4%
0.01%
Q1 2016$14,000
-22.2%
398
-4.8%
0.00%
-100.0%
Q4 2015$18,0000.0%418
-0.7%
0.00%0.0%
Q3 2015$18,000
-18.2%
4210.0%0.00%0.0%
Q2 2015$22,000
+37.5%
4210.0%0.00%0.0%
Q1 2015$16,000
-72.4%
421
-72.1%
0.00%
-50.0%
Q4 2014$58,000
+9.4%
1,5110.0%0.00%0.0%
Q3 2014$53,000
+29.3%
1,5110.0%0.00%0.0%
Q2 2014$41,000
+5.1%
1,5110.0%0.00%
+100.0%
Q1 2014$39,0001,5110.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2015
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders